Skip to main content

Table 2 Baseline data completeness by randomised group

From: Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial

Variable, n (%)

SMS messaging

(N = 103)

Usual care

(N = 106)

Total

(N = 209)

Notes review

 Height

97 (94.2)

96 (90.6)

193 (92.3)

 HbA1c

101 (98.1)

99 (93.4)

200 (95.7)

 Total cholesterol

87 (84.5)

78 (73.6)

165 (78.9)

 HDL cholesterol

96 (93.2%)

93 (87.7%)

189 (90.4%)

 Blood pressure

103 (100.0)

104 (98.1)

207 (99.0)

 Weight

100 (97.1)

102 (96.2)

202 (96.7)

 MI

103 (100.0)

104 (98.1)

207 (99.0)

 Stroke

103 (100.0)

104 (98.1)

207 (99.0)

 TIA

103 (100.0)

104 (98.1)

207 (99.0)

 Heart failure

103 (100.0)

104 (98.1)

207 (99.0)

 PVD

103 (100.0)

104 (98.1)

207 (99.0)

 Renal failure

103 (100.0)

104 (98.1)

207 (99.0)

 Smoking status

101 (98.1)

105 (99.1)

206 (98.6)

Self-reported questionnaires

 EQ-5D-5L1

103 (100.0)

105 (99.1)

208 (99.5)

 MARS1,2

97 (94.2)

100 (94.3)

197 (94.3)

 Health care psychology3

103 (100.0)

106 (100.0)

209 (100.0)

 Health services use3

103 (100.0)

106 (100.0)

209 (100.0)

  1. 1Number (%) indicates the number of participants who returned questionnaires and all items were completed
  2. 2Medication adherence rating scale (5 items)
  3. 3Number (%) represents the number of participants who returned the questionnaire